Amgen: Top figures - | Stock surges to the top of the Dow: The figures were absolutely impressive.
deraktionaer.de/artikel/pharma-biotech/amgen-top-zahlen-aktie-schnellt-an-die-dow-spitze-20433536.html
Amgen says 'breakthrough' drug improves lung cancer survival rate by 58 per cent: The company says the results are ‘unprecedented’
independent.co.uk/news/science/lung-cancer-treatment-amgen-imdelltra-b3072900.html
The FDA wants to pull its approval of a drug. It’s not so easy.: The regulator says Tavneos was approved on the basis of manipulated study data ...
arstechnica.com/science/2026/10/the-fda-wants-to-pull-its-approval-of-a-drug-its-not-so-easy/
STAT Oct 27
Roche gets a lung cancer win with its KRAS drug divarasib: Roche drug, which inhibits G12C KRAS mutations in second-line advanced non-small cell lung cancer ...
statnews.com/2026/10/26/roche-kras-drug-divarasib-lung-cancer-treatment-win/
Paid articlePaywall
Barron's Oct 26
Moderna’s Cancer Vaccine Rally Hits a Wall. This Other Drugmaker Stole the Show.: Amgen showcases “excellent” data for its small-cell lung cancer treatment ...
barrons.com/articles/moderna-merck-stocks-cancer-vaccines-66e87b5d
Paid articlePaywall
help.medscape.com Oct 23
Improving the Care of People With Obstructive Sleep Apnea: Are you missing hidden OSA phenotypes? Move beyond one-size-fits-all care to recognize diverse ...
medscape.org/advances/improving-care-people-obstructive-sleep-apnea-2026a10011u4
Bayer to invest $2.2 billion in Ohio pharma facility, creating construction and permanent jobs
cleveland.com/news/2026/10/bayer-to-invest-22-billion-in-ohio-pharma-facility-creating-construction-and-permanent-jobs.html
Pelosi, LeBron & 3 Stocks To Watch Right Now: Plus, Michael Burry pivots, Anthropic IPO filing reveals major vulnerability, stock of the day, earnings, and more
benzingaringthebell.beehiiv.com/p/pelosi-lebron-3-stocks-to-watch-right-now
Amgen's autoimmune drug succeeds in late-stage trial: Amgen said on Tuesday its experimental drug to treat an autoimmune disease that attacks the body's ...
reuters.com/business/healthcare-pharmaceuticals/amgens-autoimmune-drug-succeeds-late-stage-trial-2026-09-22/
Next shock for Novo Nordisk shareholders: This is why the stock is plummeting: Novo Nordisk lowers growth expectations and warns of patent expirations ...
boerse-online.de/nachrichten/aktien/naechster-schock-fuer-novo-nordisk-aktionaere-darum-rauscht-die-aktie-ab-20409207.html
Trump says US could stay in Iran and keep oil, like Venezuela deal: He drew a parallel with the U.S. push to take control of a fifth of Venezuela's reserves.
reuters.com/business/energy/trump-says-us-could-stay-iran-keep-oil-like-venezuela-deal-2026-09-13/
Trump says US can 'easily' afford $1.2T price tag for $5K dividend to adults: President Donald Trump doubled down on his $5,000 dividend pledge at the Amgen ...
foxbusiness.com/politics/trump-says-us-can-easily-afford-1-2t-price-tag-5k-dividend-adults
Barron's Sep 08
Why Amgen Stock Is Dropping After Swiss Rival’s Trial Setback: Amgen stock drops after Novartis’ disappointing trial results.
barrons.com/articles/amgen-stock-swiss-trial-6d070c81
Paid articlePaywallAmgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial: Amgen's targeted immunotherapy, Imdelltra, combined with AstraZeneca's cancer drug ...
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-cancer-drug-combo-hits-main-survival-goal-late-stage-trial-2026-09-08/
Barron's Sep 08
The Stock Market Has Ignored the Iran Conflict. Why That’s About to Change.: Brent crude nears $100, Amgen stock falls, SpaceX valuation, the latest on the ...
barrons.com/articles/stock-market-things-to-know-today-40c7adfa
Paid articlePaywall
Heart-Drug Breakthroughs Can’t Stop Biotech Stocks From Sliding: Impressive results came out on drugs from Amgen, Arrowhead Pharmaceuticals ...
barrons.com/articles/health-stocks-heart-meds-amgen-arrowhead-crispr-fc27e160
Paid articlePaywall
Barron's Sep 01
Investors Shrug Off Good News for Heart Patients From New Meds: Impressive results came out on drugs from Amgen, Arrowhead Pharmaceuticals ...
barrons.com/articles/heart-patients-drugs-pharma-stocks-fc27e160
Paid articlePaywallAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial: AstraZeneca said on Thursday its asthma drug Tezspire met the main goals of a ...
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-asthma-drug-tezspire-meets-all-goals-late-stage-esophagitis-trial-2026-08-27/
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally: The results gave an ‘extra bounce’ to shares of several drugmakers, according to one ...
marketwatch.com/story/modernas-cancer-vaccine-breakthrough-drives-broad-biopharma-stock-rally-ff2816aa
Paid articlePaywall
Long-running hit Argenix with a price jump - | the details: Argenx shares rise after positive Phase 3 results. Analysts see potential for over one billion ...
deraktionaer.de/artikel/pharma-biotech/dauerbrenner-argenix-mit-kurssprung-die-details-20406866.html
Honeywell's quantum computing unit is targeting a $12.7 billion valuation in its U.S. IPO
qz.com/honeywell-quantinuum-ipo-valuation-nasdaq-052626
Amgen is pouring another $300 million into its Puerto Rico drug factory: The additional investment builds on $650 million Amgen committed to its Juncos facility ...
qz.com/amgen-300-million-puerto-rico-biologics-plant-050426
How This Amgen Rival, Up 30%, Plans To Shake Its Grip In Thyroid Eye Disease: Viridian Therapeutics unveiled solid results Tuesday for its experimental eye ...
investors.com/news/technology/viridian-therapeutics-stock-amgen-tepezza-thryoid-eye-disease/
S&P 500 Hits New High on Apple Earnings: Stock Market Today: Apple rounded out a big week of mega-cap earnings on a high note, sending two of the three main ...
kiplinger.com/investing/stocks/s-and-p-500-hits-new-high-on-apple-earnings-stock-market-today
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
cnbc.com/2026/04/27/lpa-drugs-from-novartis-amgen-and-eli-lilly-aim-to-prevent-heart-attacks.html
Amgen Unveils Upbeat Results For Tepezza After Rival Eye Disease Drug Disappoints
investors.com/news/technology/amgen-viridian-therapeutics-thyroid-eye-disease/
Barron's Apr 09
We Picked Amgen Stock a Year Ago. Stick With the Emerging GLP-1 Play.: Amgen has performed decently but it’s best returns are still ahead.
barrons.com/articles/amgen-stock-follow-up-stick-with-emerging-glp-1-play-9cd88492
Paid articlePaywall Barron's Apr 06
Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.
barrons.com/articles/viridian-therapeutics-stock-amgen-eye-disease-91dcd4c5
Paid articlePaywall Viridian Therapeutics Crashes On 'Positive, But Lackluster' Thyroid Eye Disease Results
investors.com/news/technology/viridian-therapeutics-thyroid-eye-disease-treatment-amgen-tepezza/
Biotechs: Rocket Stocks from the Lab: Biotech stocks like Amgen have performed strongly since 2008, with innovations in medicine and acquisitions that have ...
deraktionaer.de/artikel/deraktionaermagazin/biotechs-kursraketen-aus-dem-labor-20397437.html
When the body's own immune system attacks the eyes / Biotechnology company Amgen focuses on research for...
presseportal.de/pm/30303/6234617
The Dow's best dividend stocks: A shortlist for income investors : For investors looking to build an income-generating portfolio, the Dow Jones Industrial ...
miamiherald.com/news/business/article314863131.html
Rare Disease Day 2026: Making Endocrine Orbitopathy (EO) Visible: Munich (ots) - | - | Protruding eyeballs can indicate a rare autoimmune disease - | Visible ...
presseportal.de/pm/30303/6224488
AI to Drive the Next Scientific Revolution in Drug Discovery, Says Amgen CSO: Dr Chang said AI is being used from the earliest stages of molecule discovery to ...
deccanchronicle.com/southern-states/telangana/ai-to-drive-the-next-scientific-revolution-in-drug-discovery-says-amgen-cso-1938011
Stocks making the biggest moves midday: MGM Resorts, Amgen, Advanced Micro Devices, Enphase & more
cnbc.com/2026/02/04/stocks-making-the-biggest-moves-midday-mgm-amgn-amd-enph.html
Paid articlePaywall Sanofi and Amgen: Is this approach facing its end? Shareholder tip benefits!: Amgen and Sanofi are struggling with side effects in OX40 programs for atopic ...
deraktionaer.de/artikel/pharma-biotech/sanofi-und-amgen-droht-diesem-ansatz-das-aus-aktionaer-tipp-profitiert-20394697.html
Paid articlePaywallStocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more
cnbc.com/2026/01/07/stocks-making-the-biggest-moves-midday-deck-amgn-wdc.html
Paid articlePaywall Evotec after recent rally - | this is important now: Evotec receives Gates funding for AI development of cost-effective antibodies.
deraktionaer.de/artikel/pharma-biotech/evotec-nach-juengster-rally-das-ist-jetzt-wichtig-20393144.html
Up to $618 million: Amgen bets on Cologne biotech company: Amgen buys Dark Blue Therapeutics and closes deal with DISCO Pharma for up to $618 million for cancer ...
deraktionaer.de/artikel/pharma-biotech/bis-zu-618-millionen-dollar-amgen-wettet-auf-koelner-biotech-firma-20392966.html
Columbus’s Reputation as an Affordable City Is Making Its Homes More Expensive: The city’s Goldilocks status as an employer magnet with still-reasonable housing ...
wsj.com/real-estate/columbus-ohio-housing-affordability-de355f5e
Paid articlePaywall Wall Street update: Sentiment is turning! McDonald's and Amgen in demand, Axon and Pinterest down double digits
deraktionaer.de/artikel/aktien/wall-street-update-stimmung-dreht-sich-mcdonalds-und-amgen-gefragt-axon-und-pinterest-zweistellig-im-minus-20389819.html
These stocks are oversold and could bounce back: A disappointing week for the market isn't bad news for all stocks, as several beaten-down names in the S&P 500 ...
cnbc.com/2025/11/08/these-stocks-are-oversold-and-could-bounce-back.html
Paid articlePaywall Amgen Surges On Broad-Based Beat As Investors Zone In On Obesity: Amgen stock popped Wednesday on a solid third-quarter beat as investors focus on what's next ...
investors.com/news/technology/amgen-stock-amgen-earnings-q3-2025/
